Literature DB >> 21040309

Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review.

Ann P Murchison1, Joseph D Walrath, Carl V Washington.   

Abstract

The diagnosis and management of periocular cutaneous malignancies are essential components of an ophthalmologist's practice. Skin cancers comprise nearly one-third of newly diagnosed malignancies. Furthermore, the incidence of skin cancer appears to be increasing. Multiple treatment modalities exist for periocular cutaneous malignancy. Surgical extirpation, often with the combined expertise of a Mohs micrographic surgeon, is typically the first line therapy and is often curative in the periocular region, depending on a variety of factors, including tumour histology, specific location, depth of invasion and surgical technique. However, there are instances where a less invasive, non-surgical treatment option is warranted, including patients who are poor surgical risks or those with diffuse disease. The purpose of this article is to review the literature and describe the non-surgical treatment options, indications and efficacies for non-melanoma primary eyelid malignancies.
© 2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21040309     DOI: 10.1111/j.1442-9071.2010.02422.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  9 in total

Review 1.  Applications of stem cell biology to oculoplastic surgery.

Authors:  Michael G Daniel; Albert Y Wu
Journal:  Curr Opin Ophthalmol       Date:  2016-09       Impact factor: 3.761

2.  Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.

Authors:  M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

Review 3.  Oculoplastic aspects of ocular oncology.

Authors:  C Rene
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

4.  Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale.

Authors:  Sarbani Ghosh Laskar; Trinanjan Basu; Suresh Chaudhary; Devendra Chaukar; Mandar Nadkarni; Manjunatha Gn
Journal:  J Contemp Brachytherapy       Date:  2014-11-06

5.  Superpulsed CO 2 Laser with Intraoperative Pathologic Assessment for Treatment of Periorbital Basal Cell Carcinoma Involving Eyelash Line.

Authors:  Ali Ebrahimi; Mansour Rezaei; Reza Kavoussi; Mojtaba Eidizadeh; Seyed Hamid Madani; Hossein Kavoussi
Journal:  Dermatol Res Pract       Date:  2014-10-13

Review 6.  Brachytherapy in non melanoma skin cancer of eyelid: a systematic review.

Authors:  Rezarta Frakulli; Andrea Galuppi; Silvia Cammelli; Gabriella Macchia; Simona Cima; Maria A Gambacorta; Ines Cafaro; Luca Tagliaferri; Elisabetta Perrucci; Milly Buwenge; Giovanni Frezza; Vincenzo Valentini; Alessio G Morganti
Journal:  J Contemp Brachytherapy       Date:  2015-12-16

7.  Holding back the tears: is there a role for marsupialisation?

Authors:  Stephanie J Chiu; Zanna I Currie; Jennifer Hy Tan
Journal:  BMJ Open Ophthalmol       Date:  2022-08

Review 8.  Using stem cell biology to study and treat ophthalmologic and oculoplastic diseases.

Authors:  Albert Y Wu; Michael G Daniel
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun

9.  Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.

Authors:  Andrea Vavassori; Giulia Riva; Stefano Durante; Cristiana Fodor; Stefania Comi; Raffaella Cambria; Federica Cattani; Giuseppe Spadola; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2019-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.